MALVERN, Pa.--(BUSINESS WIRE)--May 1, 2006--Orthovita, Inc. (NASDAQ NM:VITA - News), a developer of orthopedic biomaterials, reported financial results for the quarter ended March 31, 2006. Product sales for the three months ended March 31, 2006 increased 37% to $10,817,000, as compared to $7,886,000 for the same period in 2005. Sales growth for the reported period was primarily attributable to the expansion of our VITAGEL® and VITOSS® FOAM product portfolios as well as improved market penetration in the U.S. as we further develop our U.S. field sales network.
